It is currently Sat Mar 28, 2015 8:10 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Fampridine SR

One of the companies I monitor closely is Acorda Therapeutics who are focussed on restoring neurological function. Here are the results from the Fampridine trial which is to improve walking. ... highlight=
Read more : Fampridine SR | Views : 1402 | Replies : 1 | Forum : Drug Pipeline

I eliminated my post

I eliminated my post
Read more : I eliminated my post | Views : 3388 | Replies : 1 | Forum : Mental & Spiritual Health


I guess I get to be a guinea pig of sorts, only inadvertantly, as I started Tomaxifen three days ago as a preventative for reoccurrence of breast cancer. It was highly recommended by the oncologist that I do this as statistically the tomaxifen would provide a significant reduction in all breast cancer events. So of course I decided that I should add this to my regimin of drugs that I take. But he also had ...
Read more : tomaxifenprov | Views : 1927 | Replies : 3 | Forum : Regimens


This is interesting, and they do mention neurodegenerative disorders.

IBM & Genome Institute of Singapore Collaboration May Lead to Better Understanding of Cell Process Regulation

22 Sept 2006 -- IBM, in collaboration with the Genome Institute of Singapore (GIS), today revealed results from a joint research study that could potentially alter our views of how cell processes are regulated.

The two teams have discovered that microRNAs, small molecules that are an important regulatory component in ...
Read more : microRNAs | Views : 2363 | Replies : 15 | Forum : General Discussion

Would Like To Say Hello

Hi, my name's Nina, I'm 50 and waiting to be diagnosed after a very long wait.

I hope you don't mind me being here but I'd really appreciate any help I can get to help me on my journey.

It's quite a site here!! It will take a bit of getting used to but I'd like to stick around if you'll have me.

Take care all. :D ...
Read more : Would Like To Say Hello | Views : 1368 | Replies : 3 | Forum : Introductions


I think this is interesting because taurine is one of the main ingredients in energy drinks like Red Bull. The study seem relevant to MS since neuroprotection is obviously key, and mitochondrial dysfunction is being increasingly implicated in MS.

Taurine increases mitochondrial buffering of calcium: role in neuroprotection.

Amino Acids. 2006 Sep 8;
El Idrissi A.
Department of Biology and Center for Developmental Neuroscience, College of Staten Island of the City University of New York, ...
Read more : Taurine | Views : 2436 | Replies : 8 | Forum : General Discussion

Biogen and PML

Another Partner for Biogen
By Brian Lawler
September 21, 2006

It seems that not a week goes by when I'm not writing about Biogen IDEC (Nasdaq: BIIB) licensing a drug or signing up a new partner. For a biopharmaceutical company of its size, Biogen definitely takes the cake as the most prolific drug-acquirer.

After the market closed yesterday, Biogen added another collaboration agreement with Alnylam Pharmaceuticals (Nasdaq: ALNY) to its long list of partners. This ...
Read more : Biogen and PML | Views : 861 | Replies : 1 | Forum : General Discussion

Merck financial news

Found this info kind of interesting considering Merck's MS candidate seems to have failed.

Merck to take control of Swiss drug maker
By Carter Dougherty International Herald Tribune

Published: September 21, 2006

FRANKFURT Merck of Germany announced Thursday that it would take control of Serono, a Swiss pharmaceutical maker, for €10.6 billion after failing to secure a merger with Schering, its German competitor, this year.

A deal with Schering would have created a German powerhouse ...
Read more : Merck financial news | Views : 785 | Replies : 0 | Forum : General Discussion

DIRECT-MS sponsors a vitamin D trial

A Dose/Safety Study of Vitamin D for Persons with Multiple Sclerosis

Introduction – Beginning in 2000, Direct-MS has strongly advocated the use of adequate vitamin D supplementation for the prevention and treatment of multiple sclerosis. Since that time we have also actively promoted the need for clinical research to test the effectiveness of vitamin D for preventing and treating MS. Before clinical trials to test the efficacy of vitamin D for MS can be done, ...
Read more : DIRECT-MS sponsors a vitamin D trial | Views : 1145 | Replies : 3 | Forum : General Discussion

DIRECT-MS funding a clinical trial to test the Best Bet Diet

Testing the Effectiveness of the Best Bet Diet for Decreasing Disease Activity in Multiple Sclerosis

Introduction Direct-MS is very pleased to be funding a rigorous clinical trial which will test the effectiveness of the Direct-MS recommended nutritional strategies, often referred to as the Best Bet Diet for MS (BBD), for affecting MS disease activity. Such research is of critical importance for determining if the recommended nutritional strategies are of value for MS and thus ...
Read more : DIRECT-MS funding a clinical trial to test the Best Bet Diet | Views : 1627 | Replies : 4 | Forum : General Discussion


Login  •  Register


Total posts 224352 • Total topics 23423 • Total members 14837

Contact us | Terms of Service